337
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Five-Year Trend of Malaria Prevalence in Mojo Town, Central Ethiopia: Shifting Burden of the Disease and Its Implication for Malaria Elimination: A Retrospective Study

ORCID Icon, &
Pages 455-464 | Published online: 11 Feb 2022

References

  • World Health Organization. World malaria report 2021. World Health Organization; 2021.
  • World Health Organization. World malaria report 2020: 20 years of global progress and challenges. World Health Organization; 2020.
  • Beeson JG, Chu CS, Richards JS, Nosten F, Fowkes FJI. Plasmodium vivax malaria: challenges in diagnosis, treatment and elimination. Pediatr Infect Dis J. 2015;34(5):529–531. doi:10.1097/INF.0000000000000671
  • Worldwide Antimalarial Resistance Network. Vivax malaria: the challenges towards malaria elimination. Worldwide Antimalarial Resistance Network (WWARN); 2017.
  • Ethiopian Public Health Institute. Ethiopia national malaria indicator survey 2015. Addis Ababa, Ethiopia: Ethiopian Public Health Institute (EPHI); 2016.
  • Berhe B, Mardu F, Legese H, Negash H. Seasonal distribution and seven year trend of malaria in North West Tigrai: 2012–2018, Ethiopia; 2019. Trop Dis Travel Med Vaccines. 2019;5(1):1–7. doi:10.1186/s40794-019-0091-y
  • Shamebo T, Petros B. Trend analysis of malaria prevalence in Halaba special district, Southern Ethiopia. BMC Res Notes. 2019;12(1):190. doi:10.1186/s13104-019-4215-2
  • Addisu A, Tegegne Y, Mihiret Y, Setegn A, Zeleke AJ. A 7-year trend of malaria at primary health facilities in Northwest Ethiopia. J Parasitol Res. 2020;2020.
  • Federal Ministry of Health. National malaria elimination road map. Federal Ministry of Health (FMOH); 2017.
  • Abamecha A, Yilma D, Addisu W, et al. Therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Chewaka District, Ethiopia. Malar J. 2020;19(1):1–10. doi:10.1186/s12936-020-03307-4
  • Teklemariam M, Assefa A, Kassa M, Mohammed H, Mamo H. Therapeutic efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in a high-transmission area in northwest Ethiopia. PLoS One. 2017;12(4):e0176004. doi:10.1371/journal.pone.0176004
  • Nega D, Assefa A, Mohamed H, et al. Therapeutic efficacy of artemether-lumefantrine (Coartem®) in treating uncomplicated P. falciparum malaria in Metehara, Eastern Ethiopia: regulatory clinical study. PLoS One. 2016;11(4):e0154618. doi:10.1371/journal.pone.0154618
  • Beyene HB, Beyene MB, Ebstie YA, Desalegn Z. Efficacy of chloroquine for the treatment of vivax malaria in Northwest Ethiopia. PLoS One. 2016;11(8):e0161483. doi:10.1371/journal.pone.0161483
  • Yeshanew S, Dagne A, Taye B. Efficacy study of chloroquine to plasmodium vivax malaria in darimu and Bure Districts, Southwest Ethiopia. Infect Drug Resist. 2021;14:795. doi:10.2147/IDR.S300692
  • United States of America Department of State/Center for Diseases Control and Prevention. President’s malaria initiative Ethiopia-malaria operational plan FY 2017. United States of America Department of State (USAID)/Center for Diseases Control and Prevention (CDC); 2017.
  • Deribew A, Dejene T, Kebede B, et al. Incidence, prevalence and mortality rates of malaria in Ethiopia from 1990 to 2015: analysis of the global burden of diseases 2015. Malar J. 2017;16(1):1–7. doi:10.1186/s12936-017-1919-4
  • Girum T, Shumbej T, Shewangizaw M. Burden of malaria in Ethiopia, 2000–2016: findings from the Global Health Estimates 2016. Trop Dis Travel Med Vaccines. 2019;5(1):1–7. doi:10.1186/s40794-019-0090-z
  • Gebretsadik D, Feleke DG, Fiseha M. Eight-year trend analysis of malaria prevalence in Kombolcha, South Wollo, north-central Ethiopia: a retrospective study. Parasit Vectors. 2018;11(1):1–6. doi:10.1186/s13071-018-2654-6
  • Alkadir S, Gelana T, Gebresilassie A. A five year trend analysis of malaria prevalence in Guba district, Benishangul-Gumuz regional state, western Ethiopia: a retrospective study. Trop Dis Travel Med Vaccines. 2020;6(1):1–7. doi:10.1186/s40794-020-0101-0
  • United States of America Department of State/Center for Diseases Control and Prevention. President’s malaria initiative Ethiopia: malaria operational plan FY 2019. United States Agency for International Development (USAID)/Center for Diseases Control and Prevention (CDC); 2019.
  • Haile D, Ferede A, Kassie B, Abebaw A, Million Y. Five-year trend analysis of malaria prevalence in Dembecha Health Center, West Gojjam zone, Northwest Ethiopia: a retrospective study. J Parasitol Res. 2020;2020. doi:10.1155/2020/8828670
  • Gemechu T, Samuel A, Yewhalaw D. Ten years trend analysis of malaria prevalence and its correlation with climatic variables in Sibu Sire District, east Wollega zone, Oromia regional state, Western Ethiopia: a retrospective study. Sci Technol Arts Res J. 2015;4(4):99–105. doi:10.4314/star.v4i4.14
  • Hawaria D, Getachew H, Zhong G, et al. Ten years malaria trend at Arjo-Didessa sugar development site and its vicinity, Southwest Ethiopia: a retrospective study. Malar J. 2019;18(1):1–11. doi:10.1186/s12936-018-2635-4
  • Esayas E, Tufa A, Massebo F, et al. Malaria epidemiology and stratification of incidence in the malaria elimination setting in Harari Region, Eastern Ethiopia. Infect Dis Poverty. 2020;9(1):1–12. doi:10.1186/s40249-020-00773-5
  • Bogale T, Asefa B. Magnitude of malaria infection in Chalia District, West Shoa Zone, Oromia Regional State, Ethiopia. J Health Med Nurs. 2017;35.
  • Yimer F, Animut A, Erko B, Mamo H. Past five-year trend, current prevalence and household knowledge, attitude and practice of malaria in Abeshge, south-central Ethiopia. Malar J. 2015;14(1):1–11. doi:10.1186/s12936-015-0749-5
  • Kalil FS, Bedaso MH, Wario SK. Trends of malaria morbidity and mortality from 2010 to 2017 in Bale Zone, Ethiopia: analysis of surveillance data. Infect Drug Resist. 2020;13:4379. doi:10.2147/IDR.S284281
  • Derbie A, Alemu M. Five years malaria trend analysis in Woreta Health Center, Northwest Ethiopia. Ethiop J Health Sci. 2017;27(5):465–472. doi:10.4314/ejhs.v27i5.4
  • Feleke DG, Gebretsadik D, Gebreweld A. Analysis of the trend of malaria prevalence in Ataye, North Shoa, Ethiopia between 2013 and 2017. Malar J. 2018;17(1):1–6. doi:10.1186/s12936-018-2474-3
  • Solomon A, Kahase D, Alemayehu M. Trend of malaria prevalence in Wolkite health center: an implication towards the elimination of malaria in Ethiopia by 2030. Malar J. 2020;19(1):1–8. doi:10.1186/s12936-020-03182-z
  • Hailemariam M, Gebre S. Trend analysis of malaria prevalence in Arsi Negelle health center, Southern Ethiopia. J Infect Dis Immun. 2015;7(1):1–6. doi:10.5897/JIDI2014.0147
  • Tangpukdee N, Duangdee C, Wilairatana P, Krudsood S. Malaria diagnosis: a brief review. Korean J Parasitol. 2009;47(2):93. doi:10.3347/kjp.2009.47.2.93
  • Chirebvu E, Chimbari MJ, Ngwenya BN. Assessment of risk factors associated with malaria transmission in Tubu village, northern Botswana. Malar Res Treat. 2014;2014:1–10. doi:10.1155/2014/403069
  • Cook J, Owaga C, Marube E, et al. Risk factors for Plasmodium falciparum infection in the Kenyan highlands: a cohort study. Trans R Soc Trop Med Hyg. 2019;113(3):152–159. doi:10.1093/trstmh/try122
  • Essendi WM, Vardo-Zalik AM, Lo E, et al. Epidemiological risk factors for clinical malaria infection in the highlands of Western Kenya. Malar J. 2019;18(1):1–7. doi:10.1186/s12936-019-2845-4
  • Habyarimana F, Ramroop S. Prevalence and risk factors associated with malaria among children aged six months to 14 years old in Rwanda: evidence from 2017 Rwanda malaria indicator survey. Int J Environ Res Public Health. 2020;17(21):7975. doi:10.3390/ijerph17217975
  • Ugwu CLJ, Zewotir T. Spatial distribution and sociodemographic risk factors of malaria in Nigerian children less than 5 years old. Geospat Health. 2020;15(2). doi:10.4081/gh.2020.819
  • Baird JK, Maguire JD, Price RN. Diagnosis and treatment of Plasmodium vivax malaria. Adv Parasitol. 2012;80:203–270. doi:10.1016/B978-0-12-397900-1.00004-9
  • Baird JK, Valecha N, Duparc S, White NJ, Price RN. Diagnosis and treatment of Plasmodium vivax malaria. Am J Trop Med Hyg. 2016;95(6_Suppl):35–51. doi:10.4269/ajtmh.16-0171
  • Cheng Q, Cunningham J, Gatton ML. Systematic review of sub-microscopic P. vivax Infections: prevalence and determining factors. PLoS Negl Trop Dis. 2015;9(1):e3413. doi:10.1371/journal.pntd.0003413
  • Jemal A, Ketema T. A declining pattern of malaria prevalence in Asendabo Health Center Jimma zone, Southwest Ethiopia. BMC Res Notes. 2019;12(1):1–5. doi:10.1186/s13104-019-4329-6
  • Aregawi M, Lynch M, Bekele W, et al. Time series analysis of trends in malaria cases and deaths at hospitals and the effect of antimalarial interventions, 2001–2011, Ethiopia. PLoS One. 2014;9(11):e106359. doi:10.1371/journal.pone.0106359
  • Minwuyelet A, Aschale Y. Analysis of five-year trend of malaria at Bichena primary hospital, Amhara Region, Ethiopia. J Parasitol Res. 2021;2021:1–6. doi:10.1155/2021/6699373
  • Price RN, Commons RJ, Battle KE, Thriemer K, Mendis K. Plasmodium vivax in the era of the Shrinking P. falciparum map. Trends Parasitol. 2020;36(6):560–570. doi:10.1016/j.pt.2020.03.009
  • Baird JK. Chloroquine Resistance inPlasmodium vivax. Antimicrob Agents Chemother. 2004;48(11):4075–4083. doi:10.1128/AAC.48.11.4075-4083.2004
  • Anstey NM, Russell B, Yeo TW, Price RN. The pathophysiology of vivax malaria. Trends Parasitol. 2009;25(5):220–227. doi:10.1016/j.pt.2009.02.003
  • Hossain MS, Commons RJ, Douglas NM, et al. The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: an individual patient data meta-analysis from the world wide antimalarial resistance network. PLoS Med. 2020;17(11):e1003393. doi:10.1371/journal.pmed.1003393
  • United Nations Development Programme. Discussion paper: gender and malaria. United Nations Development Programme (UNDP); 2015.
  • Steeg LG, Flores-Garcia Y, Zavala F, Klein SL. Irradiated sporozoite vaccination induces sex-specific immune responses and protection against malaria in mice. Vaccine. 2019;37:4468–4476. doi:10.1016/j.vaccine.2019.06.075
  • Briggs J, Teyssier N, Nankabirwa JI, et al. Sex-based differences in clearance of chronic Plasmodium falciparum infection. eLife. 2020;9:e59872. doi:10.7554/eLife.59872